MX368034B - Panel de marcadores genéticos para el diagnóstico de cáncer colorrectal. - Google Patents

Panel de marcadores genéticos para el diagnóstico de cáncer colorrectal.

Info

Publication number
MX368034B
MX368034B MX2014013684A MX2014013684A MX368034B MX 368034 B MX368034 B MX 368034B MX 2014013684 A MX2014013684 A MX 2014013684A MX 2014013684 A MX2014013684 A MX 2014013684A MX 368034 B MX368034 B MX 368034B
Authority
MX
Mexico
Prior art keywords
onset
colorectal cancer
screening
gene marker
marker panel
Prior art date
Application number
MX2014013684A
Other languages
English (en)
Other versions
MX2014013684A (es
Inventor
Molloy Peter
Lapointe Lawrence
Pedersen Susanne
Original Assignee
Clinical Genomics Pty Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Clinical Genomics Pty Ltd filed Critical Clinical Genomics Pty Ltd
Publication of MX2014013684A publication Critical patent/MX2014013684A/es
Publication of MX368034B publication Critical patent/MX368034B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/112—Disease subtyping, staging or classification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/118—Prognosis of disease development
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/154—Methylation markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Pathology (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Hospice & Palliative Care (AREA)
  • Biophysics (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)

Abstract

La presente invención se refiere un método de tamizaje para el inicio o predisposición al inicio de o el monitoreo de neoplasia del intestino grueso en un individuo, dicho método está caracterizado porque comprende evaluar el estado de metilación de: (i) la región de ADN, incluyendo 2kb hacia el extremo 5´del sitio de inicio de la transcripción de las coordinadas de HG-19: (1) chr12:24962958.24102393, en combinación con una o más de las siguientes regiones de ADN, incluyendo 2kb hacia el extremo 5´del sitio de inicio de la transcripción de las coordenadas de HG19: (2) chr7:50344378...50472798, (3) chr6:391739..411443, (4) chr12:52400748...52409671, y (5) chr6:163834097...163834982, o (ii) la región de gen, incluyendo 2kb hacia el extremo 5´de: (1) BCAT1, en combinación con una o más de las siguientes regiones de ADN, incluyendo 2kb hacia el extremo 5´ de: (2) IKZF1, (3) IRF4, (4) GRASP, y (5) CAHM, en una muestra biológica de dicho individuo en donde un nivel más alto de metilación de por lo menos una de las regiones de ADN del grupo(i) y/o (ii) con relación a los niveles de control es indicativo de neoplasia del intestino grueso o una predisposición al inicio de un estado neoplástico del intestino grueso.
MX2014013684A 2012-05-11 2013-05-10 Panel de marcadores genéticos para el diagnóstico de cáncer colorrectal. MX368034B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261646174P 2012-05-11 2012-05-11
PCT/AU2013/000481 WO2013166558A1 (en) 2012-05-11 2013-05-10 Diagnostic gene marker panel for colorectal cancer

Publications (2)

Publication Number Publication Date
MX2014013684A MX2014013684A (es) 2015-06-10
MX368034B true MX368034B (es) 2019-09-17

Family

ID=49549996

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2014013684A MX368034B (es) 2012-05-11 2013-05-10 Panel de marcadores genéticos para el diagnóstico de cáncer colorrectal.
MX2019010935A MX2019010935A (es) 2012-05-11 2014-11-10 Panel de marcadores geneticos para el diagnostico de cancer colorrectal.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2019010935A MX2019010935A (es) 2012-05-11 2014-11-10 Panel de marcadores geneticos para el diagnostico de cancer colorrectal.

Country Status (15)

Country Link
US (2) US11254985B2 (es)
EP (3) EP2847355B1 (es)
JP (3) JP6742726B2 (es)
CN (1) CN104411835B (es)
AU (3) AU2013258880B2 (es)
BR (1) BR112014028122B1 (es)
CA (3) CA3152533C (es)
DK (3) DK2847355T3 (es)
ES (1) ES2749514T3 (es)
HK (1) HK1208058A1 (es)
IL (1) IL235411A0 (es)
MX (2) MX368034B (es)
NZ (1) NZ701527A (es)
WO (1) WO2013166558A1 (es)
ZA (1) ZA201408120B (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104024427B (zh) * 2011-08-25 2018-01-02 临床基因组学私人有限公司 结直肠和乳腺癌诊断方法中的dna甲基化
BR112014028122B1 (pt) * 2012-05-11 2022-08-23 Commonwealth Scientific And Industrial Research Organisation Método para triar o princípio ou a predisposição ao princípio de neoplasma no intestino grosso ou para monitorar neoplasma no intestino grosso em indivíduo
BR112016028521B1 (pt) * 2014-06-04 2023-03-14 Clinical Genomics Pty Ltd Métodos para triagem de um neoplasma colorretal e para análise de metilação de dna, e, composição de oligonucleotídeos
EP3152332B1 (en) * 2014-06-05 2021-03-03 Clinical Genomics Pty Ltd Method for methylation analysis
WO2016201365A2 (en) * 2015-06-12 2016-12-15 Visani Giuseppe Methods for treating cancers
GB201612815D0 (en) * 2016-07-25 2016-09-07 Belgian Volition Sa Novel combination test
AU2018256387A1 (en) 2017-04-19 2019-10-31 Singlera Genomics, Inc. Compositions and methods for library construction and sequence analysis
CN109371138B (zh) * 2018-12-29 2022-10-25 上海奕谱生物科技有限公司 基于甲基化修饰的肿瘤标记物stamp-ep4
AU2019200359A1 (en) * 2019-01-18 2020-09-10 Clinical Genomics Pty Ltd Screening method
CN114207153A (zh) * 2020-03-20 2022-03-18 上海鹍远健康科技有限公司 筛查结直肠瘤的方法和试剂盒

Family Cites Families (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4883750A (en) 1984-12-13 1989-11-28 Applied Biosystems, Inc. Detection of specific sequences in nucleic acids
CA1323293C (en) 1987-12-11 1993-10-19 Keith C. Backman Assay using template-dependent nucleic acid probe reorganization
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
JPH02289917A (ja) 1990-04-25 1990-11-29 Sony Corp 回転ヘッドドラム装置
US6033854A (en) 1991-12-16 2000-03-07 Biotronics Corporation Quantitative PCR using blocking oligonucleotides
US5837832A (en) 1993-06-25 1998-11-17 Affymetrix, Inc. Arrays of nucleic acid probes on biological chips
WO1995006137A1 (en) 1993-08-27 1995-03-02 Australian Red Cross Society Detection of genes
US5830645A (en) 1994-12-09 1998-11-03 The Regents Of The University Of California Comparative fluorescence hybridization to nucleic acid arrays
US5786146A (en) 1996-06-03 1998-07-28 The Johns Hopkins University School Of Medicine Method of detection of methylated nucleic acid using agents which modify unmethylated cytosine and distinguishing modified methylated and non-methylated nucleic acids
EP1033411B1 (en) 1996-06-04 2006-02-22 University of Utah Research Foundation Fluorescent donor-acceptor pair
AU7164998A (en) 1997-04-28 1998-11-24 B-E Safe, Inc. Taxonomic identification of microorganisms, proteins and peptides involved in vertebrate disease states
US6331393B1 (en) 1999-05-14 2001-12-18 University Of Southern California Process for high-throughput DNA methylation analysis
US6180349B1 (en) 1999-05-18 2001-01-30 The Regents Of The University Of California Quantitative PCR method to enumerate DNA copy number
DE10130800B4 (de) 2001-06-22 2005-06-23 Epigenomics Ag Verfahren zum Nachweis von Cytosin-Methylierung mit hoher Sensitivität
EP1438427B1 (en) 2001-09-14 2016-04-20 Clinical Genomics Pty. Ltd Nucleic acid markers for use in determining predisposition to neoplasm and/or adenoma
EP1534865A4 (en) 2002-06-26 2005-12-21 Cold Spring Harbor Lab METHODS AND COMPOSITIONS FOR DETERMINING METHYLATION PROFILES
JP3711984B2 (ja) 2003-02-14 2005-11-02 日産自動車株式会社 ハイブリッド車両の制御装置
JP4453297B2 (ja) 2003-05-27 2010-04-21 トヨタ自動車株式会社 車両用遊星歯車式多段変速機
AU2004284456B2 (en) 2003-10-21 2012-04-19 Orion Genomics Llc Methods for quantitative determination of methylation density in a DNA locus
WO2005085477A1 (en) 2004-03-02 2005-09-15 Orion Genomics Llc Differential enzymatic fragmentation by whole genome amplification
DE602007011237D1 (de) 2006-03-28 2011-01-27 Commw Scient Ind Res Org Amplifikation von dna-fragmenten
RU2008150483A (ru) 2006-05-22 2010-06-27 Клиникал Дженомикс Пти Лтд (Au) Способ выявления
US20090170083A1 (en) * 2007-02-02 2009-07-02 Orion Genomics Llc Gene methylation in diagnosis of melanoma
US20080221056A1 (en) * 2007-02-12 2008-09-11 Johns Hopkins University Early Detection and Prognosis of Colon Cancers
WO2009043112A1 (en) 2007-10-04 2009-04-09 Commonwealth Scientific And Industrial Research Organisation Nucleic acid amplification
US20110160072A1 (en) 2007-10-23 2011-06-30 Clinical Genomics Pty. Ltd. Method of diagnosing neoplasms
EP2215257A4 (en) 2007-10-23 2010-12-01 Clinical Genomics Pty Ltd METHOD FOR DIAGNOSING TUMOR DISEASES
WO2010089538A2 (en) * 2009-02-03 2010-08-12 Oncomethylome Sciences Sa Methods of detecting colorectal cancer
WO2010135786A1 (en) 2009-05-29 2010-12-02 Clinical Genomics Pty. Ltd. A method for diagnosing neoplasms and molecules for use therein
US20130059734A1 (en) 2009-11-13 2013-03-07 Commonwealth Scientific And Industrial Research Organisation Epigenetic analysis
US20130012410A1 (en) * 2010-03-29 2013-01-10 Mayo Foundation For Medical Education And Research Methods and materials for detecting colorectal cancer and adenoma
EP2388336A1 (en) 2010-05-19 2011-11-23 Signature Diagnostics AG Method and kits for diagnosing colorectal cancer
CA2812115C (en) * 2010-09-13 2021-10-26 Clinical Genomics Pty. Ltd. Epigenetic markers of colorectal cancers and diagnostic methods using the same
US10041948B2 (en) * 2010-10-12 2018-08-07 Mayo Foundation For Medical Education And Research Materials and methods for determining cancer risk
US10767214B2 (en) 2010-10-28 2020-09-08 Clinical Genomics Pty Ltd Method of microvesicle enrichment
KR20140064732A (ko) 2011-05-05 2014-05-28 클리니칼 게노믹스 피티와이. 엘티디. 신생물을 진단하는 방법
CN104024427B (zh) 2011-08-25 2018-01-02 临床基因组学私人有限公司 结直肠和乳腺癌诊断方法中的dna甲基化
BR112014028122B1 (pt) * 2012-05-11 2022-08-23 Commonwealth Scientific And Industrial Research Organisation Método para triar o princípio ou a predisposição ao princípio de neoplasma no intestino grosso ou para monitorar neoplasma no intestino grosso em indivíduo
DK2850212T3 (da) * 2012-05-18 2020-03-23 Clinical Genomics Pty Ltd Fremgangsmåde til screening for colorektal cancer
EP2922973B1 (en) * 2012-11-26 2019-03-20 Clinical Genomics Pty Ltd A method of detecting methylation
BR112016028521B1 (pt) * 2014-06-04 2023-03-14 Clinical Genomics Pty Ltd Métodos para triagem de um neoplasma colorretal e para análise de metilação de dna, e, composição de oligonucleotídeos

Also Published As

Publication number Publication date
DK3594366T3 (da) 2021-09-13
HK1208058A1 (en) 2016-02-19
CA3152533C (en) 2023-10-17
DK2847355T3 (da) 2019-10-14
CN104411835B (zh) 2019-12-20
JP6975807B2 (ja) 2021-12-01
JP2015515862A (ja) 2015-06-04
EP3594366B1 (en) 2021-06-23
CN104411835A (zh) 2015-03-11
DK4001436T3 (da) 2024-05-27
EP3594366A1 (en) 2020-01-15
CA3083314A1 (en) 2013-11-14
JP2020089378A (ja) 2020-06-11
CA3083314C (en) 2023-01-31
MX2014013684A (es) 2015-06-10
US20220213559A1 (en) 2022-07-07
EP4001436B1 (en) 2024-03-13
EP2847355B1 (en) 2019-07-10
CA2872867A1 (en) 2013-11-14
JP2018198600A (ja) 2018-12-20
AU2013258880B2 (en) 2019-02-14
AU2019201294B2 (en) 2021-08-19
NZ701527A (en) 2016-07-29
WO2013166558A8 (en) 2014-12-11
BR112014028122B1 (pt) 2022-08-23
MX2019010935A (es) 2019-10-24
EP2847355A1 (en) 2015-03-18
EP2847355A4 (en) 2016-05-25
ES2749514T3 (es) 2020-03-20
AU2021265861A1 (en) 2021-12-02
CA2872867C (en) 2020-09-15
EP4001436A1 (en) 2022-05-25
BR112014028122A2 (es) 2017-08-15
AU2013258880A1 (en) 2014-11-20
US20150141275A1 (en) 2015-05-21
ZA201408120B (en) 2019-11-27
CA3152533A1 (en) 2013-11-14
JP6837458B2 (ja) 2021-03-03
US11254985B2 (en) 2022-02-22
JP6742726B2 (ja) 2020-08-19
IL235411A0 (en) 2014-12-31
AU2019201294A1 (en) 2019-03-14
WO2013166558A1 (en) 2013-11-14

Similar Documents

Publication Publication Date Title
MX2019010935A (es) Panel de marcadores geneticos para el diagnostico de cancer colorrectal.
MX2013000917A (es) Metodos para detectar las enfermedades o condiciones usando celulas fagociticas.
HK1211360A1 (en) Systems and methods relating to network-based biomarker signatures
MX2019008211A (es) Estructuras fibrosas que comprenden particulas y metodos para fabricarlas.
EA201590027A1 (ru) Способы детекции заболеваний или состояний
MX2016000997A (es) Metodos y composiciones para detectar contaminacion bacteriana.
JO3300B1 (ar) مركبات وتركيبات لتعديل نشاط egfr
CR20150315A (es) Biocontrol de nemátodos fitoparásitos mediante paecilomyces
MX2014000116A (es) Metodos y acidos nucleicos para determinar el pronostico de un sujeto con cancer.
MY157341A (en) Methods and compositions for treating lung cancer
EP2861753A4 (en) MICROORGANISM ASSESSMENT SYSTEM
HK1212593A1 (zh) 用順鉑脂質複合物預防癌症的肺部復發
IN2015DN01688A (es)
MX2014014464A (es) Peptidos penetrantes de celulas y metodos para identificar peptidos penetrantes de celulas.
IL236436A0 (en) Kits and methods for the detection of cyanide
EP3385717A3 (en) Methods of detecting prostate cancer
MX2014002436A (es) Marcadores de diagnostico.
HRP20200204T1 (hr) Uređaj za elektrolizu i postupak za upravljanje istim
WO2013132354A3 (en) Gene signatures associated with efficacy of postmastectomy radiotherapy in breast cancer
MY168379A (en) Air conditioner
MY170453A (en) Etching material
GB201203266D0 (en) Assay for the detection of the phenylpiperazine family
IN2012DE00794A (es)
UY33207A (es) Métodos de preparación de tiazolidinas
UA69321U (ru) (cS)-5,11,17,23-ТЕТРА-ТРЕТ.-БУТИЛ-27-ГИДРОКСИКАРБОНИЛМЕТОКСИ-25,28-ДИГИДРОКСИ-26-ПРОПОКСИКАЛИКС[4]АРЕН И (cR)-5,11,17,23-ТЕТРА-ТРЕТ-БУТИЛ-27-ГИДРОКСИКАРБОНИЛМЕТОКСИ-25,26-ДИГИДРОКСИ-28-ПРОПОКСИКАЛИКС[4]АРЕН

Legal Events

Date Code Title Description
HH Correction or change in general
FG Grant or registration